inhibitor, antithrombin III, and Cl-inactivatoronly two, 0Y2-antiplasmin and 0c2-macroglobulin, appear to be important in vivo. 0X2-Antiplasmin (see D Collen at page 24) is a specific inhibitor of plasmin which binds the enzyme instantly and irreversibly in a stoichiometric manner (1:1).
Its molar concentration in plasma is about 65% of that of plasminogen. Thus on complete activation of plasminogen in plasma only two-thirds of the resulting plasmin is inactivated by oC2-antiplasmin. The The 02M assay is based on the fact that the ac2M-plasmin complex retains its activity towards the chromogenic substrates. Hence the procedure is in three steps: (1) incubating plasmin (in excess) with plasma sample, which results in the formation of the x2M-plasmin complex; (2) inhibiting the remaining free enzyme with aprotinin; and (3) measuring the Ox2M-plasmin activity using chromogenic substrate S-2251. A straight linear relationship between the activity and cX2M concentration allows a calibration curve to be made from normal pooled plasma. Our recent studies of the interaction of 0X2M
with plasmin indicate that the use of soya bean trypsin inhibitor instead of aprotinin increases the reproducibility of this assay since the latter partly inhibits the 0c2M-plasmin complex in a progressive manner. 3 Figures 1 and 2 illustrate the usefulness of the 012-antiplasmin assay. Figure 1 shows the changes in aY2-antiplasmin in plasma during combined treatment with streptokinase and plasminogen. Interesting comparisons of the 042-antiplasmin concentrations in the plasma of two patients treated with the same standard dose of urokinase are shown in Fig. 2 
